Table 3.
Patients characteristics associated with acceptance among PWH (N = 100)
| Variable | Would accept injections (N = 74) |
Would not accept injections (N = 26) |
P |
|---|---|---|---|
| Median age (IQR), years | 50 (40–56) | 52 (47–59) | 0.18 |
| Sex, n (%) | 59 (80) | 17 (65) | 0.18 |
| Mode of transmission, n (%) | 0.072 | ||
| MSM | 41 (55) | 9 (35) | |
| Heterosexual | 21 (28) | 12 (46) | |
| Othera | 12 (16) | 5 (19) | |
| Family life: single, n (%) | 46 (62) | 13 (50) | 0.35 |
| Has children, n (%) | 29 (39) | 13 (50) | 0.36 |
| Current worker, n (%) | 56 (76) | 15 (58) | 0.13 |
| Travels, n (%) | 0.40 | ||
| 1–2/year | 34 (47) | 14 (54) | |
| > 2/year | 24 (33) | 10 (38) | |
| Never | 15 (21) | 2 (8) | |
| Current smokers, n (%) | 15 (20) | 7 (27) | 0.58 |
| Alcohol consumption: yes, n (%) | 60 (81) | 19 (73) | 0.41 |
| Drugs consumption: yes n (%) | 16 (22) | 4 (15) | 0.58 |
| IV drugs consumption: yes n (%) | 7 (9) | 1 (4) | 0.68 |
| CDC stage, n (%) | 0.72 | ||
| C | 11 (15) | 4 (15) | |
| Antiviral treatment duration, n (%) | 0.24b | ||
| < 1 year | 5 (7) | 0 (0) | |
| 1–5 year | 17 (23) | 4 (15) | |
| 5–10 year | 10 (14) | 6 (23) | |
| > 10 year | 42 (57) | 16 (62) | |
| Antiviral treatment, n (%) | 0.67 | ||
| Once a day | 68 (92) | 25 (96) | |
| STR, n (%) | 47 (64) | 18 (69) | 0.64 |
| Median CD4 (IQR), cells/µl | 746 (521–1002) | 705 (528–805) | 0.56 |
| Median CD4 nadir (IQR), cells/µl | 338 (185–446) | 292 (150–439) | 0.34 |
| Hypertension, n (%) | 18 (24) | 7 (27) | 0.80 |
| Diabetes, n (%) | 6 (8) | 2 (8) | > 0.99 |
| Hypercholesterolemia, n (%) | 20 (27) | 13 (50) | 0.051 |
| Psychiatric disorder, n (%) | 13 (18) | 2 (8) | 0.34 |
| Antidepressant, n (%) | 8 (11) | 1 (4) | 0.44 |
| Taking any non-HIV treatment, n (%) | 34 (46) | 11 (42) | 0.82 |
| Partner aware of treatment, n (%) | 59 (80) | 17 (65) | 0.18 |
| Family aware of treatment, n (%) | 37 (50) | 11 (42) | 0.65 |
| Friends aware of treatment, n (%) | 39 (53) | 8 (31) | 0.069 |
| Colleagues aware of treatment, n (%) | 11 (15) | 2 (8) | 0.50 |
| Never experienced AEs, n (%) | 41 (55) | 20 (80) | 0.034 |
| Never forgets treatment, n (%) | 48 (65) | 17 (65) | > 0.99 |
aOthers: mother to child, UIVD, unknown
bTrend test
P-values were obtained by Wilcoxon or Fisher’s exact tests